Nantahala Capital Management’s Rallybio RLYB Stock Holding History

Nantahala Capital Management’s Portfolio RLYB Stock Details RLYB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.7M	Buy	+300,635	New	+$2.06M	0.1%	125

Other funds holding RLYB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

PBPIA

Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return

5VM

5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Nantahala Capital Management's RLYB Position: Q1 2026 in Review

Nantahala Capital Management opened a new position in Rallybio (RLYB) in Q1 2026: 300,635 shares worth $2.7M. The stake represents 0.1% of the portfolio and ranks #125 among its holdings.

38 funds tracked by Wall St. Rank hold RLYB as of Q1 2026.

Nantahala Capital Management held 300,635 shares of Rallybio worth $2.7M as of Q1 2026.
Rallybio was a new Nantahala Capital Management position in Q1 2026.
Rallybio made up 0.1% of Nantahala Capital Management's portfolio in Q1 2026, its #125 holding.
38 funds tracked by Wall St. Rank held Rallybio as of Q1 2026.

Based on Nantahala Capital Management's 13F filing for Q1 2026, filed 15 May 2026.